Heerma van Voss, Marise R <br/><br/>
Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer.  [electronic resource] 

 -  Oncotarget  Sep 2015 
 - 28312-26 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.4873  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Azepines--pharmacology<br/>Basic Helix-Loop-Helix Leucine Zipper Transcription Factors--genetics<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Colorectal Neoplasms--drug therapy<br/>DEAD-box RNA Helicases--antagonists & inhibitors<br/>Dose-Response Relationship, Drug<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>HCT116 Cells<br/>HT29 Cells<br/>Humans<br/>Imidazoles--pharmacology<br/>Immunoblotting<br/>Immunohistochemistry<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy--methods<br/>Mutation<br/>RNA Interference<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Transcription Factor 4<br/>Transcription Factors--genetics<br/>Wnt Signaling Pathway--drug effects<br/>beta Catenin--genetics